Position in PFE
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$11,664,423
-$1,613,541 QoQ
Shares Held
484,403
+2.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
#383
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bell Bank holds $61,862,123 across 10 Drug Manufacturers - General names. PFE ranks #3 (18.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
53,948 | $13,575,473 | |
| 2 | AMGN |
Amgen Inc
|
33,672 | $12,193,303 | |
| 3 | PFE |
Pfizer Inc
This page
|
484,403 | $11,664,423 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
78,616 | $9,932,345 | |
| 5 | GSK |
GSK plc
|
181,234 | $9,500,285 | |
| 6 | LLY |
ELI LILLY & Co
|
2,255 | $2,704,714 | |
| 7 | JNJ |
Johnson & Johnson
|
5,046 | $1,281,532 | |
| 8 | MRK |
Merck & Co., Inc.
|
3,672 | $471,852 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,664,423 | 484,403 | Shares | Defined | 2026-07-16 | |
| 2026-03-31 | $13,277,964 | 472,862 | Shares | Defined | 2026-04-23 | |
| 2025-12-31 | $11,096,684 | 445,650 | Shares | Defined | 2026-01-14 | |
| 2025-09-30 | $11,646,754 | 457,094 | Shares | Defined | 2025-10-21 | |
| 2025-06-30 | $10,519,747 | 433,983 | Shares | Defined | 2025-07-11 | |
| 2025-03-31 | $9,288,173 | 366,542 | Shares | Defined | 2025-04-18 | |
| 2024-12-31 | $8,802,706 | 331,802 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $8,075,156 | 279,031 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $9,152,397 | 327,105 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $6,770,139 | 243,969 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $6,219,647 | 216,035 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $6,855,409 | 206,675 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $3,688,210 | 100,551 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $4,043,810 | 99,113 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $1,483,398 | 28,950 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $1,177,012 | 26,897 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $1,419,332 | 27,071 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,590,167 | 30,716 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $8,667,004 | 146,774 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $5,725,749 | 133,126 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $5,145,114 | 131,387 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $4,418,828 | 121,966 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $4,079,873 | 110,836 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $3,834,962 | 104,495 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $3,557,502 | 108,792 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,710,901 | 113,692 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||